GHCL Limited
NSE: GHCLINE539A01019·ChemicalsMicrocap 250·www.ghclindia.com ↗·Mcap ₹3,905 Cr·Listed 2003
₹419.80▼ ₹1.50  (−0.36%)
52W: ₹415 – ₹667 · Vol: 80.2K shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q4 FY26 back to Q4 FY19
₹ croreQ4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q4 FY19
Revenue from operations7917577217967817797938308237978051,0171,1191,2821,3811,3651,2731,0059838548268158074527508408360
Other income13.616.11726.723.328.717.418.316.615.611.212.422.27.98.46.15.929.74.77.55.69.64.40.88.74.20
Total expenses6446295946285965806146456706806257518089579909849178008427196836647044376637257030
EBITDA17615915719721823021121718414921329834836843442340324919318619520615976.11561741940
EBITDA margin22.2%21.0%21.8%24.8%27.9%29.5%26.6%26.1%22.4%18.7%26.5%29.3%31.1%28.7%31.4%31.0%31.7%24.8%19.6%21.7%23.6%25.3%19.8%16.8%20.8%20.7%23.2%–
Finance costs1.92.62.12.44.13.54.24.35.46.27.17.810.211.210.811.818.21517.216.618.820.123.828.533.82629.60
Depreciation27.528.827.626.928.32827.927.52625.925.924.426.831.831.830.129.229.735.23433.134.532.93334.932.532.30
Profit before tax16014314519520922719620317013319149733433340045136220615014015015711219.188.11151370
Tax44.237.437.850.558.958.941.552.745.233.148.670.982.885.299.310194.453.439.93739.239.327.86.13.217.819.70
Net profit11610610714415016815515112599.914342622725129335527116311010311111884.51384.996.91170
Net margin14.6%14.0%14.8%18.1%19.2%21.6%19.5%18.1%15.2%12.5%17.7%41.9%20.2%19.5%21.2%26.0%21.3%16.2%11.2%12.0%13.4%14.4%10.5%2.9%11.3%11.5%14.0%–
EPS (₹)12.2811.2611.1615.1015.7217.7016.2815.8113.1210.5015.0244.8226.8025.9331.4636.7328.0716.0711.5510.8011.7012.378.891.368.679.8711.910.00
Net profit YoY−23.0%−37.1%−31.1%−4.3%+20.4%+68.7%+8.4%−64.7%−44.9%−60.1%−51.2%+20.0%−16.5%+53.8%+166.1%+246.2%+144.1%+38.5%+30.2%+692.4%+31.0%+21.3%−27.7%–––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19
Revenue from operations3,0643,1833,4474,5453,7782,9003,3053,341
Other income73.487.752.339.112.12717.615.5
Total expenses2,4952,4352,7273,1972,9802,4892,8282,826
EBITDA6898768471,481979636728759
EBITDA margin22.5%27.5%24.6%32.6%25.9%21.9%22.0%22.7%
Finance costs916.125.538.763.691.2120127
Depreciation11111210294.2117133131117
Profit before tax6428369911,463811439495531
Tax17021219834821311298180
Net profit4726247941,142647326397351
Net margin15.4%19.6%23.0%25.1%17.1%11.2%12.0%10.5%
EPS (₹)50.1765.5083.43117.3562.8134.3240.5035.81
Net profit YoY−24.3%−21.4%−30.5%+76.5%+98.3%−17.8%+13.1%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow687638797856643
Investing cash flow−291−358−534−403−337
Financing cash flow−451−230−338−536−98.1
Capital expenditure2643151073580
Free cash flow (CFO − capex)424323691499643

Net profit trend

annual, ₹ crore
FY21
₹326
FY22
₹647+98%
FY23
₹1,142+77%
FY24
₹794−30%
FY25
₹624−21%
FY26
₹472−24%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone1 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited5 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited5 May 2026PDF on NSE XBRL
Q3 FY26Consolidated29 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone29 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated1 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone1 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated31 Jul 2025PDF on NSE XBRL
Q1 FY26Standalone31 Jul 2025PDF on NSE XBRL
Q4 FY25Consolidated · audited8 May 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 6.6×8.2×
P/B5Y avg 1.54×1.09×
ROEFY26, on average equity13.4%
Net margin15.4%
Debt / equity0.02×
Revenue CAGR (3Y)-12.3%
Profit CAGR (3Y)-25.5%
EPS (TTM)₹51.39
Market cap₹3,859 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
1.09×
vs 8-point avg 1.54× (−29%)
1.09× low1.54× avg2.06× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹4,300 Cr+3%
Net worth₹3,552 Cr+2%
Total borrowings₹62 Cr−36%
Cash & bank balances₹44 Cr−55%
Investments₹1,042 Cr+60%
Inventories₹597 Cr−5%
Trade receivables₹173 Cr−18%
Trade payables₹280 Cr+70%
Change vs the same date a year earlier.
Revenue mix FY22
Inorganic Chemocals75.6%result ₹694 Cr
Textiles24.4%result ₹225 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter19.8319.8719.8319.8318.9718.9719.0419.0419.0419.0419.0419.03
FII22.4324.6625.2225.1825.6726.4126.0725.4225.7024.7624.9924.66
DII11.2210.579.509.5010.5310.2910.1110.379.819.308.318.62
of which MF9.538.977.907.918.978.81––––––
Retail27.6926.1026.1826.2126.1226.1026.0626.0125.8727.5028.2028.34
Other public18.8318.8019.2719.2818.7118.2318.7219.1619.5819.4019.4619.35
98,031 shareholders · NSE shareholding pattern filings.